跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DEXMEDETOMIDINE KABI dexmedetomidine (as hydrochloride) 400 micrograms/4 mL concentrated injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
DEXMEDETOMIDINE KABI dexmedetomidine (as hydrochloride) 400 micrograms/4 mL concentrated injection vial
Approved
STANDARD
DEXMEDETOMIDINE KABI dexmedetomidine (as hydrochloride) 400 micrograms/4 mL concentrated injection vial
Fresenius Kabi Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
ee40ddebaa6d1dde
Company
Fresenius Kabi Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
ee40ddebaa6d1dde
Product Name
DEXMEDETOMIDINE KABI dexmedetomidine (as hydrochloride) 400 micrograms/4 mL concentrated injection vial
Artg Id
379590
Artg Name
DEXMEDETOMIDINE KABI dexmedetomidine (as hydrochloride) 400 micrograms/4 mL concentrated injection vial
Sponsor
Fresenius Kabi Australia Pty Ltd
Company Detail Path
/organization/fresenius-kabi-australia-pty-ltd
Artg Date
2022-11-23
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
ee40ddebaa6d1dde
Type
Standard
Back to TGA Approvals
